Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its participation as a sponsor of the PDA Pharmaceutical Microbiology Conference 2026, taking place in Washington, D.C. from October 26-28.
Covered in this story
Call it yourself
No calls on $RPID yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rapid Micro Biosystems →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.